Literature DB >> 18703318

Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.

S Faruqi, J McCreanor, T Moon, R Meigh, A H Morice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18703318     DOI： 10.1016/j.ijantimicag.2008.05.010

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa.

Authors:  Alexandro Rodríguez-Rojas; Alejandro Couce; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 2.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

Review 3.  New antimicrobial strategies in cystic fibrosis.

Authors:  Mireille van Westreenen; Harm A W M Tiddens
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

Review 4.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

5.  The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis.

Authors:  Mohamed Al-Aloul; Dilip Nazareth; Martin Walshaw
Journal:  Clin Kidney J       Date:  2019-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.